Pharmaceutical Intermediates Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Pharmaceutical Intermediates market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period.

    This report presents the market size and development trends by detailing the Pharmaceutical Intermediates market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmaceutical Intermediates market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharmaceutical Intermediates industry and will help you to build a panoramic view of the industrial development.

    Pharmaceutical Intermediates Market, By Type:

    • GMP

    • Non-GMP

    Pharmaceutical Intermediates Market, By Application:

    • Antibiotics

    • Antipyretic Analgesics

    • Vitamins

    • Others

    Some of the leading players are as follows:

    • Ganesh

    • Granules

    • Porton

    • Jubilant

    • Chemcon

    • Catalent

    • Tianma

    • Jiuzhou

    • BASF

    • Jiujiujiu

    • Patheon

    • ABA Chem

    • Yongtai

    • Lianhetech

    • Alpha

    • Lonza

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Pharmaceutical Intermediates Market: Technology Type Analysis

    • 4.1 Pharmaceutical Intermediates Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Pharmaceutical Intermediates Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 GMP

      • 4.3.2 Non-GMP

    5 Pharmaceutical Intermediates Market: Product Analysis

    • 5.1 Pharmaceutical Intermediates Product Market Share Analysis, 2018 & 2026

    • 5.2 Pharmaceutical Intermediates Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Pharmaceutical Intermediates Market: Application Analysis

    • 6.1 Pharmaceutical Intermediates Application Market Share Analysis, 2018 & 2026

    • 6.2 Pharmaceutical Intermediates Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Antibiotics

      • 6.3.2 Antipyretic Analgesics

      • 6.3.3 Vitamins

      • 6.3.4 Others

    7 Pharmaceutical Intermediates Market: Regional Analysis

    • 7.1 Pharmaceutical Intermediates Regional Market Share Analysis, 2018 & 2026

    • 7.2 Pharmaceutical Intermediates Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Ganesh

      • 9.1.1 Ganesh Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Granules

      • 9.2.1 Granules Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Porton

      • 9.3.1 Porton Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Jubilant

      • 9.4.1 Jubilant Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Chemcon

      • 9.5.1 Chemcon Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Catalent

      • 9.6.1 Catalent Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Tianma

      • 9.7.1 Tianma Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Jiuzhou

      • 9.8.1 Jiuzhou Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 BASF

      • 9.9.1 BASF Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Jiujiujiu

      • 9.10.1 Jiujiujiu Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Patheon

      • 9.11.1 Patheon Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 ABA Chem

      • 9.12.1 ABA Chem Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Yongtai

      • 9.13.1 Yongtai Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Lianhetech

      • 9.14.1 Lianhetech Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Alpha

      • 9.15.1 Alpha Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Lonza

      • 9.16.1 Lonza Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

     

    The List of Tables and Figures (Totals 97 Figures and 144 Tables)

    • Figure GMP Pharmaceutical Intermediates market, 2015 - 2026 (USD Million)

    • Figure Non-GMP Pharmaceutical Intermediates market, 2015 - 2026 (USD Million)

    • Figure Antibiotics market, 2015 - 2026 (USD Million)

    • Figure Antipyretic Analgesics market, 2015 - 2026 (USD Million)

    • Figure Vitamins market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

    • Table North America Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table North America Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table North America Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Canada Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Canada Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Germany Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Germany Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table France Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table France Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Italy Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Italy Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Spain Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Spain Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table China Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table China Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Japan Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Japan Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table India Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table India Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates market, by country, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Pharmaceutical Intermediates market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Pharmaceutical Intermediates market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Pharmaceutical Intermediates market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Ganesh Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Granules Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Porton Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Jubilant Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Chemcon Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Catalent Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Tianma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Jiuzhou Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BASF Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Jiujiujiu Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Patheon Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ABA Chem Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Yongtai Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lianhetech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alpha Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lonza Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.